In most of the IFN-α associated PAHs, there are also other risk factors of PAH; although some patients has not any other risk factors and in some, PAH has developed before IFN-α therapy, but progressed with this treatment to more severe disease.3 Here, IFNA1 is linked to pulmonary arterial hypertension.